Drug Trial Radar · NCT06439602
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
818
Actual
Start
Jun 26, 2024
Primary completion
Mar 20, 2026
Study completion Apr 10, 2026
Sponsor
- Lead sponsor
- Arthrosi TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months
Conditions
- Gout
- Arthritis, Gouty
- Hyperuricemia
- Gout Chronic
Interventions
AR882 50 mgDrug
Solid Oral Capsule
AR882 75 mgDrug
Solid Oral Capsule
PlaceboDrug
Matching Solid Oral Capsule Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serum urate (uric acid) (sUA) level < 6 mg/dL at month 6Time frame: 24 weeks
Locations
68 sites in 5 countries. Site status is shown where the registry gives one.
Arthrosi Investigative Site (106)
Foley, Alabama
Arthrosi Investigative Site (139)
Anchorage, Alaska
Arthrosi Investigative Site (160)
Peoria, Arizona
Arthrosi Investigative Site (112)
Phoenix, Arizona
Arthrosi Investigative Site (114)
Tempe, Arizona
Arthrosi Investigative Site (131)
El Cajon, California
Arthrosi Investigative Site (117)
Encinitas, California
Arthrosi Investigative Site (138)
Rancho Cucamonga, California
Arthrosi Investigative Site (161)
Valencia, California
Arthrosi Investigative Site (101)
Aurora, Colorado
Arthrosi Investigative Site (149)
Clearwater, Florida
Arthrosi Investigative Site (115)
Coral Gables, Florida
Arthrosi Investigative Site (128)
DeLand, Florida
Arthrosi Investigative Site (102)
Hollywood, Florida
Arthrosi Investigative Site (156)
Maitland, Florida
Arthrosi Investigative Site (103)
Miami, Florida
Arthrosi Investigative Site (157)
Palmetto Bay, Florida
Arthrosi Investigative Site (151)
Winter Haven, Florida
Arthrosi Investigative Site (164)
Atlanta, Georgia
Arthrosi Investigative Site (162)
Lilburn, Georgia
Arthrosi Investigative Site (133)
Boise, Idaho
Arthrosi Investigative Site (122)
River Forest, Illinois
Arthrosi Investigative Site (154)
Wichita, Kansas
Arthrosi Investigative Site (144)
New Orleans, Louisiana
Arthrosi Investigative Site (150)
Hagerstown, Maryland
Arthrosi Investigative Site (121)
Ann Arbor, Michigan
Arthrosi Investigative Site (105)
Detroit, Michigan
Arthrosi Investigative Site (153)
Olive Branch, Mississippi
Arthrosi Investigative Site (119)
Kansas City, Missouri
Arthrosi Investigative Site (158)
Brooklyn, New York
Arthrosi Investigative Site (137)
Greensboro, North Carolina
Arthrosi Investigative Site (140)
Shelby, North Carolina
Arthrosi Investigative Site (130)
Wilmington, North Carolina
Arthrosi Investigative Site (148)
Cleveland, Ohio
Arthrosi Investigative Site (146)
Dayton, Ohio
Arthrosi Investigative Site (120)
Hatboro, Pennsylvania
Arthrosi Investigative Site (147)
Myrtle Beach, South Carolina
Arthrosi Investigative Site (132)
Rapid City, South Dakota
Arthrosi Investigative Site (110)
Amarillo, Texas
Arthrosi Investigative Site (104)
Dallas, Texas
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.